Kr Pharma Caps Profile
Key Indicators
- Authorised Capital ₹ 1.25 Cr
- Paid Up Capital ₹ 1.25 Cr
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.02 Cr
- Revenue Growth -17.67%
- Profit Growth 224.48%
- Ebitda -110.86%
- Net Worth 24.64%
- Total Assets -6.23%
About Kr Pharma Caps
Kr Pharma Caps Private Limited (KPCPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 September 2016 (Eight years and four months 30 days old ). Its registered office is in Nashik, Maharashtra, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.25 Cr and a paid-up capital of Rs 1.25 Cr.
The company currently has active open charges totaling ₹4.02 Cr.
Kailas Ghule and Rajesh Ghule serve as directors at the Company.
Company Details
-
Location
Nashik, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999MH2016PTC286025
-
Company No.
286025
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Sep 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Kr Pharma Caps?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kailas Ghule
|
Director | 19-Sep-2016 | Current |
|
Rajesh Ghule
|
Director | 19-Sep-2016 | Current |
Financial Performance of Kr Pharma Caps.
Kr Pharma Caps Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 17.67% decrease. The company also saw a substantial improvement in profitability, with a 224.48% increase in profit. The company's net worth Soared by an impressive increase of 24.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kr Pharma Caps?
In 2019, Kr Pharma Caps had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Kailesh Raja Infrastructure LlpKailas Ghule is a mutual person
-
Prius Global Private Limited
Kailas Ghule is a mutual person
-
Kailasraja Infra And Motels Private Limited
Kailas Ghule and Rajesh Ghule are mutual person
-
Health Express Diagnostics Private Limited
Kailas Ghule is a mutual person
Charges (Loans)
₹4.02 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 4.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2017 | Others | ₹4.02 Cr | Open |
How Many Employees Work at Kr Pharma Caps?
Unlock and access historical data on people associated with Kr Pharma Caps, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kr Pharma Caps, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kr Pharma Caps's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.